期刊文献+

甲状腺功能与ICU感染性休克患者预后的相关性 被引量:1

下载PDF
导出
摘要 目的:回顾性分析血清甲状腺功能与ICU感染性休克患者预后之间的关系。方法:选择入住ICU感染性休克患者51例,根据28 d生存情况,分为存活组(23例)和非存活组(28例),评估两组甲状腺功能[促甲状腺激素(thyroid stimulating hormone,TSH)、四碘甲状腺原氨酸(tetraiodothyronine,T4)、游离甲状腺素(free thyroxine,FT4)、三碘甲状腺原氨酸(triiodothyronine,T3)、游离三碘甲状腺原氨酸(free triiodothyronine,FT3)]水平与预后关系。结果:感染性休克非存活组的甲状腺功能(TSH、T4、FT4、T3、FT3)分别是(0.22±0.16)μIU/mL、(3.09±0.88)μg/dL、(1.16±0.43)ng/dL、(0.47±0.16)ng/mL、(1.53±0.72)pg/mL;感染性休克存活组的甲状腺功能(TSH、T4、FT4、T3、FT3)是(0.08±0.07)μIU/mL、(4.10±0.89)μg/dL、(1.27±0.56)ng/dL、(0.50±0.16)ng/mL、(1.42±0.46)pg/mL,两者的TSH、T4、FT4、T3、FT3水平皆低,但感染性休克非存活组与存活组相比,有更低水平的T4(P<0.01)和更高水平TSH(P=0.01)。结论:感染性休克患者伴有不同程度的甲状腺功能减退,其T4、TSH水平与预后相关。
出处 《南通大学学报(医学版)》 2014年第1期43-45,共3页 Journal of Nantong University(Medical sciences)
  • 相关文献

参考文献7

  • 1孙菁,周进祝.内科学[M].6版.北京:科学出版社,2003:797-798.
  • 2Dellinger RP, Carlet JM, Masur H, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock[J]. Crit Care Med, 2004, 32(3):585-873.
  • 3罗洁,王德明.非甲状腺疾病综合征对危重症患者的影响[J].中国实用医药,2010,5(36):247-248. 被引量:13
  • 4Singer M, De Santis V, Vitale D, et al. Multiorgan failure is an adaptive, endocrine -mediated, metabolic response to overwhelming systemic inflammation[J]. Lancet, 2004, 364 (9433):545-548.
  • 5Klein JR. Physiological relevance of thyroid stimulating hormone and thyroid stimulating hormone receptor in tis?sues other than the thyroid[J]. Autoimmunity, 2003, 36(6/7): 417-421.
  • 6den Brinker M, Dumas B, Visser TJ, et al. Thyroid function and outcome in children who survived meningococcal sep?tic shock[J]. Intensive Care Med, 2005, 31(7):970-976.
  • 7Inan M, Koyuncu A, Aydin C, et al. Thyroid hormone supplementation in sepsis: an experimental study[J]. Surg Today, 2003, 33(1):24-29.

二级参考文献14

  • 1Maria H Warner,Geoffrey J Beckett.Mechanisms behind the non-thyroidal illness syndrome:an update.Journal of Endocrinology,2010,205:1-13.
  • 2Hennemann G,Krenning EP.The kinetics of thyroid hormone transporters and their role in non-thyroidal llness and starvation.BestPractRes Clin EndocrinolMetab,2007,21(2):323-338.
  • 3Fliers E,Alkemade A,Wiersinga WM & Swaab DF.Hypothalamic thyroid hormone feedback in health and disease.Progress in Brain Research,2006,153:189-207.
  • 4Boelen A,Kwakkel J,Wieland CW.Impaired bacterial clearance in type 3 deiodinase-deficient mice infected with Streptococcus pneumoniae.Endocrinology,2009,150:1984-1990.
  • 5St Germain DL,Galton VA & Hernandez A.Minireview:defining the roles of the iodothyronine deiodinases:current concepts and challenges.Endocrinology,2009,150:1097-1107.
  • 6Lechan RM.The dilemma of the nonthyroidal illness syndrome.Acta Biomedica,2008,79:165-171.
  • 7Mebis L,Debaveye Y,Ellger B,et al.Changes in the central component of the hypothalamus-pituitary-thyroid axis in a rabbit model of prolonged critical illness.Critical Care 2009,13:147.
  • 8Dagan O,Vidne B,Josefsberg Z,et al.Relationship between changes in thyroid hormone level and severity of the postoperative course in neonates undergoing open-heart surgery.Paediatr Anaesth,2006,16(5):538-542.
  • 9Zargar AH,Ganie MA,Masocdi SR,et al.Prevalence and pattern of euthyroid sick syndrome in acute and chronic non-thyroidal illnessits relationship with severity and outcome of the disorder.J Assoc Physieians India,2004,52(1):27-31.
  • 10Iglesias P,Díez JJ.Thyroid dysfunction and kidney disease.Eur J Endocrino,2009,160(4):503-515.

共引文献13

同被引文献12

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部